Identification of mite-specific eosinophils in the colon of patients with ulcerative colitis

References

• Ungaro R, Mehandru S, Allen PB, et al. Ulcerative colitis. Lancet. 2017;389(10080):1756–1770.
   PubMed Web of Science ®Google Scholar
• Porter RJ, Kalla R, Ho GT. Ulcerative colitis: recent advances in the understanding of disease pathogenesis. F1000Res. 2020;9:294.
   Google Scholar
• Tulic MK, Vivinus-Nébot M, Rekima A, et al. Presence of commensal house dust mite allergen in human gastrointestinal tract: a potential contributor to intestinal barrier dysfunction. Gut. 2016;65(5):757–766.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kim ME, Shin YS, et al. Safety of ultra-rush schedule of subcutaneous allergen immunotherapy with house dust mite extract conducted in an outpatient clinic in patients with atopic dermatitis and allergic rhinitis. Allergy Asthma Immunol Res. 2019;11(6):846–855.
   PubMed Web of Science ®Google Scholar
• Beute J, Ganesh K, Nastiti H, et al. PDE3 inhibition reduces epithelial mast cell numbers in allergic airway inflammation and attenuates degranulation of basophils and mast cells. Front Pharmacol. 2020;11:470.
   PubMed Web of Science ®Google Scholar
• Costello SP, Hughes PA, Waters O, et al. Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA. 2019;321(2):156–164.
   PubMed Web of Science ®Google Scholar
• Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353(23):2462–2476.
   PubMed Web of Science ®Google Scholar
• Skierka AS, Michels KB. Ethical principles and placebo-controlled trials - interpretation and implementation of the Declaration of Helsinki’s placebo paragraph in medical research. BMC Med Ethics. 2018;19(1):24.
   PubMedGoogle Scholar
• Kim JH, Lee JH, Ye YM, et al. Efficacy and safety of sublingual immunotherapy in elderly rhinitis patients sensitized to house dust mites. Allergy Asthma Immunol Res. 2018;10(6):675–685.
   PubMed Web of Science ®Google Scholar
• Chen H, Li J, Cheng L, et al. China consensus document on allergy diagnostics. Allergy Asthma Immunol Res. 2021;13(2):177–205.
   PubMed Web of Science ®Google Scholar
• Pfistershammer K, Majdic O, Stöckl J, et al. CD63 as an activation-linked T cell costimulatory element. J Immunol. 2004;173(10):6000–6008.
   PubMed Web of Science ®Google Scholar
• Mahmudi-Azer S, Downey GP, Moqbel R. Translocation of the tetraspanin CD63 in association with human eosinophil mediator release. Blood. 2002;99(11):4039–4047.
   PubMed Web of Science ®Google Scholar
• Pesek RD, Rothenberg ME. Eosinophilic gastrointestinal disease below the belt. J Allergy Clin Immunol. 2020;145(1):87–89. e1.
   PubMed Web of Science ®Google Scholar
• Valenta R, Hochwallner H, Linhart B, et al. Food allergies: the basics. Gastroenterology. 2015;148(6):1120–1131.e4.
   PubMed Web of Science ®Google Scholar
• Kita H, Kaneko M, Bartemes KR, et al. Does IgE bind to and activate eosinophils from patients with allergy? J Immunol. 1999;162(11):6901–6911.
   PubMed Web of Science ®Google Scholar
• Evans H, Killoran KE, Mitre BK, et al. Ten weeks of infection with a tissue-invasive helminth protects against local immune complex-mediated inflammation, but not cutaneous type I hypersensitivity, in previously sensitized mice. J Immunol. 2015;195(7):2973–2984.
   PubMed Web of Science ®Google Scholar
• Esnault S, Johansson MW, Kelly EA, et al. IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation. Clin Exp Allergy. 2017;47(4):488–498.
   PubMed Web of Science ®Google Scholar
• An YF, Suo LM, Xue JM, et al. Role of FcγRI in antigen-dependent eosinophil activation in patients with allergic rhinitis. Am J Rhinol Allergy. 2021;35(1):86–97.
   PubMed Web of Science ®Google Scholar
• Lin J, Feng BS, Huang N, et al. Enolase-specific cross antibodies induce neutrophilic inflammation in the intestine. J Leukoc Biol. 2021;109(3):633–644.
   PubMed Web of Science ®Google Scholar
• Calderón MA, Linneberg A, Kleine-Tebbe J, et al. Respiratory allergy caused by house dust mites: what do we really know? J Allergy Clin Immunol. 2015;136(1):38–48.
   PubMed Web of Science ®Google Scholar
• Sands BE, Sandborn WJ, Panaccione R, et al. Ustekinumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2019;381(13):1201–1214.
   PubMed Web of Science ®Google Scholar
• Wilson JM, Platts-Mills TAE. Home environmental interventions for house dust mite. J Allergy Clin Immunol Pract. 2018;6(1):1–7.
   PubMed Web of Science ®Google Scholar
• Seumois G, Ramírez-Suástegui C, Schmiedel BJ, et al. Single-cell transcriptomic analysis of allergen-specific T cells in allergy and asthma. Sci Immunol. 2020;5(48):eaba6087.
   PubMed Web of Science ®Google Scholar
• Yusoff FM, Wong KK, Mohd Redzwan N. Th1, Th2, and Th17 cytokines in systemic lupus erythematosus. Autoimmunity. 2020;53(1):8–20.
   PubMed Web of Science ®Google Scholar
• Nemeth ZH, Bogdanovski DA, Barratt-Stopper P, et al. Crohn’s disease and ulcerative colitis show unique cytokine profiles. Cureus. 2017;9(4):e1177.
   PubMed Web of Science ®Google Scholar
• Heller F, Florian P, Bojarski C, et al. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129(2):550–564.
   PubMed Web of Science ®Google Scholar
• Hoving JC. Targeting IL-13 as a host-directed therapy against ulcerative colitis. Front Cell Infect Microbiol. 2018;8:395.
   PubMed Web of Science ®Google Scholar
• Hammad H, Chieppa M, Perros F, et al. House dust mite allergen induces asthma via toll-like receptor 4 triggering of airway structural cells. Nat Med. 2009;15(4):410–416.
   PubMed Web of Science ®Google Scholar
• Lee EH, Shin MH, Gi M, et al. Inhibition of pendrin by a small molecule reduces lipopolysaccharide-induced acute lung injury. Theranostics. 2020;10(22):9913–9922.
   PubMed Web of Science ®Google Scholar
• Wansook S, Mahasongkram K, Chruekamlow N, et al. Anti-human CD63 monoclonal antibody COS3A upregulates monocyte-induced IL-10 excretion leading to diminution of CD3-mediated T cell response. Mol Immunol. 2019;114:591–599.
   PubMed Web of Science ®Google Scholar
• Luck W, Becker M, Niggemann B, et al. In vitro release of eosinophil cationic protein from peripheral eosinophils reflects disease activity in childhood Crohn disease and ulcerative colitis. Eur J Pediatr. 1997;156(12):921–924.
   PubMed Web of Science ®Google Scholar